Strategies for improving patient outcome in patients with familial adenomatous polyposis

Bibliography

• Bertario L, Presciuttini S, Sala P, et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol 1994;10:225-34
   PubMedGoogle Scholar
• Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993;36:1059-62
   PubMed Web of Science ®Google Scholar
• Gibbons DC, Sinha A, Phillips RK, et al. Colorectal cancer: no longer the issue in familial adenomatous polyposis? Fam Cancer 2011;10:11-20
   PubMed Web of Science ®Google Scholar
• Herrera L, Kakati S, Gibas L, et al. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25:473-6
   PubMed Web of Science ®Google Scholar
• Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-16
   PubMed Web of Science ®Google Scholar
• Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5
   PubMed Web of Science ®Google Scholar
• Nagase H, Miyoshi Y, Horii A, et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992;52:4055-7
   PubMed Web of Science ®Google Scholar
• Nugent KP, Phillips RK, Hodgson SV, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 1994;35:1622-3
   PubMed Web of Science ®Google Scholar
• Caspari R, Friedl W, Mandl M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994;343:629-32; Erratum appears in Lancet 1994;343(8901):863
   PubMed Web of Science ®Google Scholar
• Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75:951-7
   PubMed Web of Science ®Google Scholar
• Dobbie Z, Spycher M, Hurliman R, et al. Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene. Eur J Cancer 1994;30A:1709-13
   PubMed Web of Science ®Google Scholar
• van der Luijt RB, Vasen HF, Tops CM, et al. APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum Genet 1995;96:705-10
   PubMed Web of Science ®Google Scholar
• Friedl W, Meuschel S, Caspari R, et al. Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 1996;97:579-84
   PubMed Web of Science ®Google Scholar
• Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumors and lack of opthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995;4:337-40
   PubMed Web of Science ®Google Scholar
• Sturt NJ, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004;53:1832-6
   PubMed Web of Science ®Google Scholar
• Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9
   PubMed Web of Science ®Google Scholar
• Briggs S, Tomlinson I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 2013;230:148-53
   PubMed Web of Science ®Google Scholar
• Spier I, Horpaopan S, Vogt S, et al. Deep intronic APC mutations explain a substantial proportion of patients with familial or early-onset adenomatous polyposis. Hum Mutat 2012;33:1045-50
   PubMed Web of Science ®Google Scholar
• Tuohy TM, Done MW, Lewandowski MS, et al. Large intron 14 rearrangement in APC results in splice defect and attenuated FAP. Hum Genet 2010;127:359-69
   PubMed Web of Science ®Google Scholar
• Crabtree MD, Tomlinson IP, Hodgson SV, et al. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 2002;51:420-3
   PubMed Web of Science ®Google Scholar
• Latchford AR, Neale KF, Spigelman AD, et al. Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2009;7:659-63
   PubMed Web of Science ®Google Scholar
• Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 1978;2:85-8
   PubMed Web of Science ®Google Scholar
• Bulow S, Bulow C, Vasen H, et al. Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 2008;51:1318-23
   PubMed Web of Science ®Google Scholar
• Church J, Burke C, McGannon E, et al. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 2003;46:1175-81
   PubMed Web of Science ®Google Scholar
• Tajika M, Nakamura T, Nakahara O, et al. Prevalence of adenomas and carcinomas in the ileal pouch after proctocolectomy in patients with familial adenomatous polyposis. J Gastrointest Surg 2009;13:1266-73
   PubMed Web of Science ®Google Scholar
• von Roon AC, Tekkis PP, Clark SK, et al. The impact of technical factors on outcome of restorative proctocolectomy for familial adenomatous polyposis. Dis Colon Rectum 2007;50:952-61
   PubMed Web of Science ®Google Scholar
• Smith JC, Schaffer MW, Ballard BR, et al. Adenocarcinomas after prophylactic surgery for familial adenomatous polyposis. J Cancer Ther 2013;4:260-70
   PubMedGoogle Scholar
• Durno C, Monga N, Bapat B, et al. Does early colectomy increase desmoid risk in familial adenomatous polyposis? Clin Gastroenterol Hepatol 2007;5:1190-4
   PubMed Web of Science ®Google Scholar
• Xhaja X, Church J. Desmoid disease and the ileal pouch revisited. Fam Cancer 2013;12:S108
   Google Scholar
• Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention. A case report. Cancer 1995;75:936-8
   PubMed Web of Science ®Google Scholar
• Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994;107:854-7
   PubMed Web of Science ®Google Scholar
• Gurbuz AK, Giardiello FM, Peterson GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-81
   PubMed Web of Science ®Google Scholar
• Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42
   PubMed Web of Science ®Google Scholar
• Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185-9
   PubMed Web of Science ®Google Scholar
• Latchford AR, Sturt NJ, Neale K, et al. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 2006;93:1258-64
   PubMed Web of Science ®Google Scholar
• Lynch HT, Fitzgibbons R. Surgery, desmoid tumors and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996;91:2598-601
   PubMed Web of Science ®Google Scholar
• Penna C, Tiret E, Parc R, et al. Operation and abdominal desmoid tumours in familial adenomatous polyposis. Surg Gynecol Obstet 1993;177:263-8
   PubMedGoogle Scholar
• Middleton SB, Pack K, Clark SK, et al. Measurement of telomeres in FAP-associated desmoids. Gastroenterology 1999;116:G2037-7
   Web of Science ®Google Scholar
• Rodriguez JA, Guarda LA, Rosai J. Mesenteric fibromatosis with involvement of the gastrointestinal tract. A GIST simulator: a study of 25 cases. Am J Clin Pathol 2004;121:93-8
   PubMed Web of Science ®Google Scholar
• Church JM. Desmoid tumors in patients with familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:29-32
   Google Scholar
• Phillips SR, A'Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 2004;91:1624-9
   PubMed Web of Science ®Google Scholar
• Wood TJ, Quinn KM, Farrokhyar F, et al. Local control of extra-abdominal desmoid tumors: systematic review and meta-analysis. Rare Tumors 2013;5:e2
   Google Scholar
• Micke O, Seegenschmiedt MH. Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 2005;61:882-91
   PubMed Web of Science ®Google Scholar
• Nuyttens JJ, Rust PF, Thomas CR Jr, et al. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 2000;88:1517-23
   PubMed Web of Science ®Google Scholar
• Bocale D, Rotelli MT, Cavallini A, et al. Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review. Colorectal Dis 2011;13:e388-95
   PubMed Web of Science ®Google Scholar
• Gounder MM, Lefkowitz RA, Keohan ML, et al. Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res 2011;17:4082-90
   PubMed Web of Science ®Google Scholar
• Latchford A, Volikos E, Johnson V, et al. APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’. Hum Mol Genet 2007;16:78-82
   PubMed Web of Science ®Google Scholar
• Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783-5
   PubMed Web of Science ®Google Scholar
• Offerhaus GJA, Giardello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2
   PubMed Web of Science ®Google Scholar
• Bulow S, Bjork J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381-6
   PubMed Web of Science ®Google Scholar
• Bjork J, Akerbrant H, Iselius L, et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001;121:1127-35
   PubMed Web of Science ®Google Scholar
• Burke CA, Beck GJ, Church JM, et al. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999;49:358-64
   PubMed Web of Science ®Google Scholar
• Domizio P, Talbot IC, Spigelman AD, et al. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990;43:738-43
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Spigelman AD, Debinski HS, et al. Surveillance of ampullary adenomas in familial adenomatous polyposis. Lancet 1994;344:1582
   PubMed Web of Science ®Google Scholar
• Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Spigelman AD, Talbot IC, et al. Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg 1996;83:225-8
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Spigelman AD, Talbot IC, et al. p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br J Surg 1997;84:826-9
   PubMed Web of Science ®Google Scholar
• Gallinger S, Vivona AA, Odze RD, et al. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. Oncogene 1995;10:1875-8
   PubMed Web of Science ®Google Scholar
• Bulow S, Christensen IJ, Hojen H, et al. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 2012;14:947-52
   PubMed Web of Science ®Google Scholar
• Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704-13
   PubMed Web of Science ®Google Scholar
• Phillips RK, Wallace MH, Lynch PM, et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis (FAP). Gut 2002;50(6):857-60
   PubMed Web of Science ®Google Scholar
• Jaganmohan S, Lynch PM, Raju RP, et al. Endoscopic management of duodenal adenomas in familial adenomatous polyposis–a single-center experience. Dig Dis Sci 2012;57:732-7
   PubMed Web of Science ®Google Scholar
• Latchford A, Gallagher M, Newton D, et al. Endoscopic therapy for duodenal adenomas in familial adenomatous polyposis. International Society for Gastrointestinal Hereditary Tumours, Yokohama; 2007
   Google Scholar
• Ouaissi M, Panis Y, Sielezneff I, et al. Long-term outcome after ampullectomy for ampullary lesions associated with familial adenomatous polyposis. Dis Colon Rectum 2005;5:187-95
   Google Scholar
• van Heumen BW, Nieuwenhuis MH, van Goor H, et al. Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study. Surgery 2012;151:681-90
   PubMed Web of Science ®Google Scholar
• Skipworth JR, Morkane C, Raptis DA, et al. Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford) 2011;13:342-9
   PubMed Web of Science ®Google Scholar
• Alderlieste YA, Bastiaansen BA, Mathus-Vliegen EM, et al. High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis. Fam Cancer 2013;12(4):699-706
   PubMed Web of Science ®Google Scholar